Hikma Pharmaceuticals PLC HIK shares shed 3.16% to £19.02 Friday, on what proved to be an all-around rough trading session ...

Hikma Pharmaceuticals KSA, announced the expansion of its strategic partnership with the Saudi Gastroenterology Association ...

IBD is a chronic inflammation of the intestine characterised by severe stomach pain and diarrhoea affecting nearly 5 million ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The acquisition includes a commercial portfolio and pipeline of differentiated products, a manufacturing facility in ...

Saudi Ministry of Health supports December launch event in Riyadh; Event to highlight Saudi Arabia’s ambitious pharma goals, ...

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Hyphens Pharma International (Catalist:1J5). Now this is not to say ...

Worldcategory Dechra, Hikma, M&S and Diploma set to join FTSE ... Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media ...

LONDON, Aug. 20, 2024 /PRNewswire/ -- Hikma Pharmaceuticals (OTC:HKMPY) in the US joined government officials and non-profit leaders today at a naloxone awareness and training ...

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables ...

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables ...